[1] 何丽丽,曹国磊,董春岚,等.恶性肿瘤并发静脉血栓栓塞症的特点分析.重庆医学,2020,49(23):3893-3896.
[2] 彭德清,司菲,吕梅叶,等.防治医院获得性静脉血栓栓塞症信息化系统的建立与实践.中华护理杂志,2023,58(14):1719-1725.
[3] Timp JF,Braekkan SK,Versteeg HH,et al.Epidemiology of cancer-associated venous thrombosis.Blood,2013,122(10):1712-1723.
[4] Shargall Y,Litle VR.European perspectives in Thoracic Surgery,the ESTS venous thromboembolism (VTE) working group.J Thorac Dis,2018,10(Suppl 8):S963-S968.
[5] Khorana AA,Kuderer NM,Culakova E,et al.Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood,2008,111(10):4902-4907.
[6] WHO Expert Consultation.Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet,2004,363(9403):157-163.
[7] Harrell,FE.Regression modeling strategies:with applications to linear models,logistic regression,and survival analysis.Springer,2010.
[8] 马军,秦叔逵,吴一龙,等.肿瘤相关静脉血栓栓塞症预防与治疗指南(2019版).中国肿瘤临床,2019,46(13):653-660. |
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
